☰

Karen M. Kaluza, Ph.D. - Publications

Affiliations: 
2011 Immunology College of Medicine - Mayo Clinic 
Area:
Immunology, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Research. 73: 3591-603. PMID 23633484 DOI: 10.1158/0008-5472.CAN-12-4100  0.474
2013 Kaluza KM, Vile R. Improving the outcome of adoptive cell transfer by targeting tumor escape. Oncoimmunology. 2: e22059. PMID 23483796 DOI: 10.4161/Onci.22059  0.73
2012 Rommelfanger DM, Wongthida P, Diaz RM, Kaluza KM, Thompson JM, Kottke TJ, Vile RG. Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer. Cancer Research. 72: 4753-64. PMID 22836753 DOI: 10.1158/0008-5472.Can-12-0600  0.692
2012 Kaluza KM, Kottke T, Diaz RM, Rommelfanger D, Thompson J, Vile R. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape. Human Gene Therapy. 23: 1054-64. PMID 22734672 DOI: 10.1089/Hum.2012.030  0.763
2012 Kaluza KM, Thompson JM, Kottke TJ, Flynn Gilmer HC, Knutson DL, Vile RG. Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants. International Journal of Cancer. Journal International Du Cancer. 131: 844-54. PMID 21935923 DOI: 10.1002/Ijc.26447  0.767
2011 Wongthida P, Diaz RM, Pulido C, Rommelfanger D, Galivo F, Kaluza K, Kottke T, Thompson J, Melcher A, Vile R. Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus. Human Gene Therapy. 22: 1343-53. PMID 21366404 DOI: 10.1089/Hum.2010.216  0.703
2008 Kottke T, Diaz RM, Kaluza K, Pulido J, Galivo F, Wongthida P, Thompson J, Willmon C, Barber GN, Chester J, Selby P, Strome S, Harrington K, Melcher A, Vile RG. Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1910-8. PMID 18827807 DOI: 10.1038/Mt.2008.212  0.695
2008 Kaluza K, Vile RG. Magnetic cells for cancer therapy: Adopting magnets for cell-based cancer therapies Gene Therapy. 15: 1511-1512. PMID 18719530 DOI: 10.1038/Gt.2008.139  0.541
Show low-probability matches.